tm logo
LIBERCHLO
Dead/Abandoned
ABANDONED – EXPRESS AFTER PUB

on 08 Jun 2021

Last Applicant/ Owned by

235 East 42nd Street

New York

NY

10017

Serial Number

88160471 filed on 18th Oct 2018

Registration Number

N/A

Correspondent Address

Andrea Christensen

Pfizer Inc.

235 East 42nd Street

New York NY 10017

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

LIBERCHLO

Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations forRead More

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, liver disorders, erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations and smoking cessation preparations; vaccines for human use

Mark Details


Serial Number

No 88160471

Mark Type

No Service/Collective Mark

Attorney Docket Number

No T424186

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
08th Jun 2021ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION
08th Jun 2021ABANDONMENT - AFTER PUBLICATION
07th Jun 2021TEAS EXPRESS ABANDONMENT RECEIVED
30th Mar 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
26th Mar 2021TEAS EXTENSION RECEIVED
26th Mar 2021EXTENSION 4 GRANTED
26th Mar 2021EXTENSION 4 FILED
18th Sep 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
16th Sep 2020EXTENSION 3 GRANTED
16th Sep 2020TEAS EXTENSION RECEIVED